Supreme Industries Limited (SUPREMEIND)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- H1 FY27 revenue Rs 6079 Cr (+22% value), volume 341,991 MT (+1%)
- H1 FY27 standalone OP Rs 829 Cr (+34%), PAT Rs 487 Cr (+31%)
- Q2 volume growth: Plastic Piping +24%, Packaging +3%, Industrial +13%, Consumer volume -14%
- FY27 volume growth guidance ~10%, operating margin 14-14.5%
- Capex guidance Rs 700-750 Cr for FY27
- PVC piping growth driven mainly by housing; Nal Se Jal volumes expected lower
- Price hikes in PVC/cPVC passed with 10-15 days lag to support distributors
- Inventory gains expected by March 2027
- Packaging margins pressured by high raw material costs linked to crude
- Employee costs up due to increments and new units
- October piping volume growth ~23% y-o-y
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 SUPREMEIND — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add SUPREMEIND to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Supreme Industries Limited
Important.
The summary above is generated automatically from Supreme Industries Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.